Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [543]

Immunotherapy treatment for melanoma

Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA

Immunotherapy treatment for melanoma ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )

Advances in the treatment of lung cancer and melanoma

Dr Raffaele Califano - The Christie NHS Foundation Trust, Manchester, UK

Advances in the treatment of lung cancer and melanoma ( Dr Raffaele Califano - The Christie NHS Foundation Trust, Manchester, UK )

Roundup of the EMCC 2011 conference

Prof Gordon McVie - European Institute of Oncology and ecancer

Roundup of the EMCC 2011 conference ( Prof Gordon McVie - European Institute of Oncology and ecancer )

Genetic mutations as causes of cancer

Dr Henry Lynch - Creighton University, Omaha, USA

Genetic mutations as causes of cancer ( Dr Henry Lynch - Creighton University, Omaha, USA )

Early detection and prevention of melanoma (6/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Early detection and prevention of melanoma (6/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Guidelines and recommendations for advanced melanoma (5/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Guidelines and recommendations for advanced melanoma (5/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Combination of newer agents in advanced melanoma (4/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Combination of newer agents in advanced melanoma (4/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Recent advances in advanced melanoma: BRAF inhibitors (3/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Recent advances in advanced melanoma: BRAF inhibitors (3/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Recent advances in advanced melanoma: ipilimumab (2/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Recent advances in advanced melanoma: ipilimumab (2/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Metastatic melanoma: changes in epidemiology and current standards of care (1/6)

European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf

Metastatic melanoma: changes in epidemiology and current standards of care (1/6) ( European Post ASCO Meeting 2011 - Prof Axel Hauschild, Prof Michele Maio, Prof Paul Lorigan, Prof Dirk Schadendorf )

Improving pre-clinical experimental models to test anti cancer drugs

Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada

Improving pre-clinical experimental models to test anti cancer drugs ( Dr Robert Kerbel - Sunnybrook Research Institute, University of Toronto, Canada )

Early stage molecular profiling

Prof Razelle Kurzrock - MD Anderson Cancer Centre, Houston, USA

Early stage molecular profiling ( Prof Razelle Kurzrock - MD Anderson Cancer Centre, Houston, USA )

More from ecancer